Abstract
We have developed and characterized cultures of healthy and dystrophic canine myoblasts for the evaluation of various gene transfer protocols. The number of desmin-positive myoblasts was elevated (>>80%) in cultures of myoblasts obtained from different muscle territories, the diaphragm muscle giving rise to the purest cultures. Myoblasts from dogs turned out to be a very convenient source of well transfectable and transducible cells. Transfection with plasmid DNA allowed efficient transgene expression (50% of β-galactosidase positive cells and about 375 ng luciferase/mg protein after transfection with a calcium phosphate-precipitated plasmid). Infection with high concentrations of adenoviral and retroviral vectors allowed transgene (β-galactosidase or mini-dystrophin) detection in about 75 to 90% of the canine cells. Therefore, primary dog myoblast cultures represent a useful in vitro model for viral and non-viral gene delivery, as well as for functional evaluation and cell grafting with applications in genetic diseases, vaccination or production of circulating therapeutic proteins.
Similar content being viewed by others
References
Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA and Davies KE (1991) Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352: 815-818.
Askanas V and Engel WK (1975) A new program for investigating adult human skeletal muscle grown aneurally in tissue culture. Neurology 25: 58-67.
Askanas V and Gallez-Hawkins G. (1985) Synergistic influence of polypeptide growth factors on cultured human muscle. Arch Neurol 42: 749-752.
Bischoff R, Cordier Y, Perraud F, Thioudellet C, Braun S, and Pavirani A (1997) Transfection of myoblasts in primary culture with isomeric cationic cholesterol derivatives. Anal Biochem 254: 69-81.
Bonavaud S, Thibert P, Gherardi RK and Barlovatz-Meimon G (1997) Primary human muscle satellite cell culture: variations of cell yield, proliferation and differentiation rates according to age and sex of donors, site of muscle biopsy, and delay before processing. Biol Cell 89: 233-240.
Brinkhous KM (1992) Gene transfer in the hemophilias: retrospect and prospect. Thromb Res 67: 329-338.
Chiu RC, Zibaitis A and Kao RL (1995) Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 60: 12-18.
Cooper BJ, Winand NJ, Stedman H, et al. (1988) The homologous of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334: 154-156.
Cooper BJ (1990) The role of the xmd dog in the assessment of myoblast transfer therapy. Adv Exp Med Biol 280: 279-282.
Felgner JH, Kumar R, Sridnar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M and Felgner PL (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269: 2550-2561.
Ferrara ML, Occhiodoro T, Fuller M, Hawthorne WJ, Teutsch S, Tucker VE, Hopwood JJ, Stewart GJ and Anson DS (1997) Neuromuscul Disord 7: 361-366.
Gao X and Huang L (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun 179: 280-285.
Gautier C, Mehtali M and Lathe R. (1989) A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter. Nucleic Acids Res. 17: 8389.
Graham FL and Prevec L (1991) Manipulation of adenovirus vectors. Methods Mol Biol 7: 109-128.
Graham FL, Smiley J, Russell WC and Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
Graham FL and Van der Eb AJ (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467.
Grounds MD (1996) Commentary on the present state of knowledge for myoblast transfer therapy. Cell Transplant 5: 431-433.
Hall CV, Jacob PE, Ringold GM and Lee F (1983) Expression and regulation of Escherichia coli lac Z gene fusions in mammalian cells. J Mol Appl Genet 2: 101-109.
Howell JMcC, Fletcher S, Kakulas BA, O'Hara M, Lochmuller H and Karpati G (1997) Use of the dog model for Duchenne muscular dystrophy in gene therapy trials. Neuromuscul Disord 7: 325-328.
Howell JM, Fletcher S, O'Hara A, Johnsen RD, Lloyd F and Kakulas BA (1998) Direct dystrophin and reporter gene transfer into dog muscle in vivo. Muscle and Nerve 21: 159-165.
Ito H, Vilquin JT, Skuk D, Roy B, Goulet M, Lille S, Dugré FJ, Asselin I, Roy R, Fardeau M and Tremblay JP (1998) Myoblast transplantation in non-dystrophic dog. Neuromusc Disord 8: 95-110.
Lusky M, Christ M, Rittner K, Dieterle A, Dreyer D, Mourot B, Schultz H, Stoeckel F, Pavirani A and Mehtali M (1998) In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol 72: 2022-2032.
Jezyk PF (1982) Hyperkaliemic periodic paralysis in a dog. J Am Anim Hosp Assoc 18: 977-980.
Kornegay JN (1992) Golden retriever muscular dystrophy: the model and relevance to developmental therapeutics. In: Kakulas BA, Howell JmcC, Roses AD (eds) Duchenne muscular dystrophy animal models and genetic manipulation. (pp 105-108) Raven Press, New York.
MacGregor et al. (1991) Use of E coli lacZ (β-galactosidase) as a reporter gene. In: Murray EJ (ed) Methods in Molecular Biology. Vol 7 Gene transfer and expression protocols. (pp. 217-241) Humana Press: Clifton, NJ, 1991.
Manthorpe M, Cornefert-Jensen, Hartikka J, Felgner J, Rundell A, Margalith M and Dwaeki V (1993) Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 4: 419-431.
Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493-495.
Nelson TE (1991) Malignant hyperthermia in dogs. J Am Vet Med Assoc 198: 989-994.
Nicholson LV, Davison K, Falkous, G, Harwood C, O'Dinnel E, Slater CR and Harris JB (1989) Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J Neurol Sci 94: 125-136.
Pande SV and Murthy MSR (1994) A modified micro-Bradford procedure for elimination of interference from sodium dodecylsulfate, other detergents, and lipids. Anal Biochem 220: 424-426.
Peirone MA, Delaney K, Kwiecin J, Fletch A and Chang PL (1998) Delivery of recombinant gene product to canines with nonautologous microencapsulated cells. Hum Gene Ther 9: 195-206.
Sambrook J, Fritsch EF and Maniatis T (1989) Molecular cloning — A laboratory manual, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Sanes JR, Rubenstein JL and Nicolas JF (1986) Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 5: 3133-3142.
Shull RM, Lu X, McEntee MF, Bright RM, Pepper KA and Kohn DB (1996) Myoblast gene therapy in canine mucopolysaccharidosis I: abrogation by an immune response to a-L-Iduronidase. Hum Gene Ther 7: 1595-1603.
Sitbon M, Sola B, Evans L, Nishio J, Hayes SF, Nathanson K, Garon CF, Chesebro B (1986) Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell 47: 851-859.
Stratford-Perricaudet LD, Makeh I, Perricaudet M and Briand P (1992) Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 90: 626-630.
Valentine BA, Winand NJ, Pradhan D, Moise NS, de Lahunta A, Kornegay JN and Cooper BJ (1992) Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am J Med Genet 42: 352-356.
Vara J, Malpartida F, Hopwood DA and Jiménez A (1985) Cloning and expression of a puromycin N-acetyl transferase gene from Streptomyces alboniger in Streptomyces lividans and Escherichia coli. Gene 33: 197-206.
Author information
Authors and Affiliations
Additional information
Reiner Bischoff is now at
Rights and permissions
About this article
Cite this article
Braun, S., Thioudellet, C., Perraud, F. et al. Gene transfer into canine myoblasts. Cytotechnology 30, 181–189 (1999). https://doi.org/10.1023/A:1008026913715
Issue Date:
DOI: https://doi.org/10.1023/A:1008026913715